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INTRODUCTION
Endometrial hyperplasia is an abnormal proliferation
of the endometrium (i.e. greater than the normal proli-
feration that occurs during the menstrual cycle),1 and
it is the most common of Dysfunctional Uterine Blee-
ding (DUB) (90%). Endometrial hyperplasia is typical
in perimenopausal age and more frequently sympto-
matic.2,3 Endometrial hyperplasia may produce obvio-
us space occupying lesions in which diagnosis is easy
with hysteroscopy, but it may be not very obvious es-
pecially in early stages of the disease.4
Endometrial Hyperplasia
Four types of endometrial hyperplasia:1
Simple, complex, simple atypical, and complex aty-
pical.
In one study progression to carcinoma occurred
in:1
1% of patients with simple hyperplasia,
3% of patients with complex hyperplasia,
8% of patients with simple atypical hyperplasia, and
29% of patients with complex atypical hyperplasia.
Ninety percent of cases of simple and complex hy-
perplasia regress spontaneously.1 Simple hyperplasia
often regresses if the source of exogenous estrogen is
removed. However, atypical hyperplasia often pro-
gresses to adenocarcinoma unless medical interven-
tion occurs.4
Histological Appearance
The hysteroscopic diagnosis should not replace histo-
logical diagnosis, mostly in hysteroscopies performed
after progestagen therapy, because the changes indu-
ced by drugs make more difficult the interpretation
of hysteroscopy.3 Endometrial hyperplasia is a non-
physiological, non-invasive proliferation of the endo-
metrium that results in a morphological pattern of gla-
nds with irregular shapes and varying sizes.5
Simple hyperplasia/cystic hyperplasia (Figure 1)
glands are cystically dilated and with occasional out-
pouching surrounded by abundant densely cellular
stroma and give a "Swiss Cheese" appearance. No cel-
lular atypia is present.6
Complex hyperplasia (Figure 2) glands are com-
plex with papillary intraluminal tufting and irregular
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shapes accompanied by a crowded, back-to-back arra-
ngement with very little intervening stroma. Cellular
atypia is absent.6
Simple atypical hyperplasia (Figure 3) glands are
dispersed within abundant stroma and lined by enlarg-
ed cells with increased nuclear-cytoplasmic ratio and
pleomorphism.6
Complex atypical hyperplasia (Figure 4) characte-
rized by crowded glands showing cellular stratificati-
on, piling of epithelium into tufts, and atypia in the
form of enlarged, pleomorphic and hyperchromatic
nuclei and prominent nucleoli.6
Endometrial Hyperplasia Classification and Risk
of Progression to Cancer4
Endometrial hyperplasia may be a precursor to the
most common female genital malignancy, endometrial
carcinoma. Unopposed estrogens from anovulatory
cycles and exogenous use in postmenopausal women
have been shown to increase the likelihood of endo-
metrial hyperplasia and endometrial carcinoma. Less
than 2% of hyperplasias without atypia progress to
carcinoma, and the mean duration of progression to
carcinoma take almost 10 years. Atypical hyperplasia
progresses to carcinoma in 23% of cases over a mean
duration of four years.
Atypical hyperplasia can be triggered by increased
demand for that tissue or organ; chronic inflammatory
response; hormonal dysfunction; or neoplasia. Or it
may be triggered by no obvious cause at all. Even if
the atypical hyperplasia is not cancerous, it will in-
crease the chances for getting cancer later. Most aty-
pical hyperplasia are triggered by a normal hyperpla-
sia. For instance, amenorrhea or oligomenorrhea may
result in thickening of the uterine endometrium, a hy-
perplasia. The increased production of cells makes it
more likely that some will mutate into a cancer. In
the endometrium, this indicates endometrial cancer.
The longer endometriosis is left untreated, the more
likely it will develop into cancer.
Postmenopausal patients with endometrial hyper-
plasia invariably present with vaginal bleeding. Al-
though carcinoma must be considered in this age
group, endometrial atrophy represents the most com-
mon cause of postmenopausal bleeding. In a study of
226 women with postmenopausal bleeding, 7% were
found to have carcinoma, 56% were noted to have
atrophy, and 15% were diagnosed with some form of
hyperplasia.
Hysteroscopy
Endoscopy began in 1805 with Bozzini but it was
Pantaleoni who, in 1869, performed the first hystero-
scopy.3 Among diagnostic techniques, hysteroscopy
presents several advantages: it is an out-patient pro-
cedure, minimally invasive, repeatable, of rapid exe-
cution and with low cost.2 Hysteroscopy has a high
diagnostic accuracy for endometrial cancer but only
moderate for hyperplasia.7
The accuracy of hysteroscopic evaluation of the
uterine cavity is extremely encouraging. Office hys-
teroscopy, which has a high diagnostic reliability and
minimal discomfort, appears to be an ideal method of
diagnosis and follow-up of patients with endometrial
hyperplasia.8 Hysteroscopic diagnostic accuracy for
hyperplasia was 72%. So, sensitivity, specificity, po-
sitive predictive value and negative predictive value
of hysteroscopy for hyperplasia were 75, 92.5, 71.4
and 93.67%, respectively. Loverro (1996), stated the
sensitivity, specificity, positive predictive value and
negative predictive value as 98, 95, 63 and 99%, res-
pectively, for endometrial hyperplasia. Arslan (2005),
did hysteroscopy in 216 premenopausal and 114 post-
menopausal women for diagnosing hyperplasia. The
positive predictive value was 71.4% and negative pre-
dictive value was 95.4% in diagnosis.9 Positive pre-
dictive value was higher in postmenopausal patients
compared to women in the fertile age (72 vs. 58%).10
The errors of hysteroscopy were observed in other
study was 8%.2
The correlations between hysteroscopic findings
with histopathologic report of hyperplasia by different
studies is shows in Table 1. Report in 100 women
between 20 and 65 years of age who presented with
complaints of abnormal uterine bleeding pattern had
undergone two modalities of investigations to reach
a conclusion - diagnostic hysteroscopy and endome-
trial histopathology report.9
Table 1. Correlation between hysteroscopic findings with
histopathologic report of hyperplasia.9
Autor Year Incident ofHyperplasia (%)
Silander8 1963  6.66
Dexus15 1981 21   
Sheth9 1989 26   
Anuradha Panda5 1999 28.3 
Jyotsana11 2004 22.6 
Present Study 2008 20   
Figure 1 Figure 2
Figure 3 Figure 4
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The hysteroscopic appearance of low risk endome-
trial hyperplasia includes an increase in the thickness
of the endometrium, its dyshomogeneous regenera-
tion, increased vascularization and the presence of ci-
liated images, cystic dilatation, increased bleeding,
polypoid formation, necrotic zones and the concentra-
tion and irregular arrangement of the glandular open-
ings. If one or more of these elements are found, hy-
perplasia must be suspected. Guided endometrial bi-
opsy can then be performed.3,4
The hysteroscopic appearance of high risk endo-
metrial hyperplasia or endometrial intraepithelial neo-
plasia (EIN) clearly defines these pre-neoplastic and
neoplastic lesions: Polyps are often present and ab-
normal vascularization produces an arborescent ap-
pearance which surrounds groups of glandular orifi-
ces. The architecture and organization of the uterine
cavity is altered. The endoscopist can easily confirm
the hysteroscopic suspicion with endometrial sam-
pling of specific areas.3,4
Investigations for Endometrial Hyperplasia
Meta analyses restricted to postmenopausal women
with abnormal bleeding show that a positive test re-
sult following hysteroscopy is more useful for predic-
ting endometrial cancer or hyperplasia disease than
TVS. In contrast, a negative test result following
Trans Vaginal Ultrasound (TVS) in postmenopausal
women (4 or 5 mm cut-off to define abnormality) is
highly accurate in excluding serious endometrial dis-
ease and more useful than hysteroscopy. Applying the
accuracy estimates from three TVS reviews, assuming
a 5% pretest probability of cancer and endometrial
thickness cut-offs of 4 or 5mm, the positive proba-
bility of cancer following a negative TVS is between
0.4 and 0.8%. Endometrial thickness measurement us-
ing ultrasound is of minimal use in premenopausal
women because specific cut-off levels or morphologi-
cal features do not accurately define the presence or
absence of endometrial hyperplasia or cancer.1
Outpatient endometrial biopsy has high accuracy
in diagnosing endometrial cancer and hyperplasia and
should be employed when serious endometrial disease
is suspected in both pre and postmenopausal women.
At the beginning of the 1990s, transvaginal sonogra-
phy greatly improved the accuracy of evaluations of
endometrial morphology, whereas in the last 10 years
hysteroscopy has become, in some hospitals, the gold
standard procedure for evaluating the uterine cavity,
particularly if performed in an office setting and if
associated with eye-guided biopsies. Hysteroscopy
without endometrial biopsy is unreliable in differen-
tiating between pre-malignant and malignant disease
in the uterine cavity, although if the cavity is clearly
atrophic it may be possible to omit endometrial sam-
pling. Endometrial cancer may be found in sympto-
matic and asymptomatic women with an essentially
atrophic or focally hyperplastic endometrium, which
cannot be detected by ultrasound.4 MRI-scan can also
demonstrate endometrial hyperplasia and, though not
often used, may be helpful in cases where TVUS is
not possible, or when superimposed invasive endome-
trial carcinoma is suspected.1
Treatment for Endometrial Hyperplasia11
Medical therapy is generally recommended for pati-
ents with non-atypical hyperplasia. Treatment for En-
dometrial Hyperplasia without atypia are progestin
therapy continuous or cyclical and repeat biopsy in 3
- 4 months. Women of childbearing age are generally
treated with progestin dominant combination OCPs.
Alternatively Depo-Provera at the usual contraceptive
dose (150mg IM q3) or oral Provera at 10mg/month
may be used. Some patients may be diagnosed via
biopsy obtained during an infertility work-up. May
follow with ovulation induction after normal biopsy
if pregnancy desired. Treatment for peri or postmena-
pausal women is similar except slightly higher doses
of progestins are used (Provera 20mg po 10 days/
month or Depo-Provera 200mg IM q2 months.
Treatment for atypical endometrial hyperplasia
when childbearing is complete is total hysterectomy
(abdominal or vaginal) as a standard treatment, but
the specimen should be examined at the time of sur-
gery to rule out a coexistent endometrial carcinoma,
which may occur as much as 20% of the time. Con-
servative medical therapy can be attempted in young-
er patients who request preservation of fertility. D&C
(possibly with hysteroscopy) should be performed
prior to initiation of medical therapy to rule out car-
cinoma. Conservative therapy may also be attempted
in young patients with early, well differentiated en-
dometrial carcinomas.
CONCLUSIONS
Endometrial hyperplasia may produce obvious space
occupying lesions in which diagnosis is easy with
hysteroscopy, but it may be not very obvious espe-
cially in early stages of the disease. Endometrial hy-
perplasia is a non-physiological, non-invasive proli-
feration of the endometrium that result in a morpho-
logical pattern of glands with irregular shapes and
varying sizes.
Among diagnostic techniques, hysteroscopy pre-
sents several advantages: it is an out-patient, proce-
dure, minimally invasive repeatable, of rapid execu-
tion and with low cost. The accuracy of hysteroscopic
evaluation of the uterine cavity is extremely encour-
aging. Office hysteroscopy, which has a high diag-
nostic reliability and minimal discomfort, appears to
be an ideal method of diagnosis and follow up of pa-
tients with endometrial hyperplasia.
Hysteroscopy has made the most significant pro-
gress, mainly because the ability to use fine diameter
instruments makes it feasible to avoid both anesthesia
and cervical dilatation. Innovation diseases through
hysteroscopy is still evolving.
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